207 related articles for article (PubMed ID: 35218954)
1. Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.
Huang Q; Mao J; Wang X; Yu B; Ma W; Ji W; Zhu Y; Zhang R; Sun B; Zhang J; Nie M; Wu X
Endocr Pract; 2022 May; 28(5):521-527. PubMed ID: 35218954
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Wang X; Zheng JJ; Liu ZX; Xu HL; Huang BK; Nie M; Wu XY
Asian J Androl; 2018; 20(4):319-323. PubMed ID: 29516878
[TBL] [Abstract][Full Text] [Related]
3. Pulsatile Gonadotropin-Releasing Hormone Therapy Is Associated With Better Spermatogenic Outcomes than Gonadotropin Therapy in Patients With Pituitary Stalk Interruption Syndrome.
Zhang J; Zhu Y; Zhang R; Liu H; Sun B; Zhang W; Wang X; Nie M; Mao J; Wu X
Endocr Pract; 2024 Feb; 30(2):146-154. PubMed ID: 38029930
[TBL] [Abstract][Full Text] [Related]
4. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
[TBL] [Abstract][Full Text] [Related]
5. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
[TBL] [Abstract][Full Text] [Related]
6. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
7. Changes in levels of testosterone, insulin sensitivity and metabolic profiles during GnRH therapy: Reciprocity between insulin sensitivity and pituitary responsiveness to GnRH in teenage and young male patients with congenital hypogonadotropic hypogonadism.
Fan HQ; Wang YC; He W; Zhou HW; Yang T
Clin Endocrinol (Oxf); 2022 Dec; 97(6):783-791. PubMed ID: 36181235
[TBL] [Abstract][Full Text] [Related]
8. [Effect of pulsatile GnRH therapy on pituitary-testicular axis function in male patients with pituitary stalk interruption syndrome].
Zheng JJ; Mao JF; Wu XY; Wang X; Liu ZX; Huang BK
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(21):1668-72. PubMed ID: 27290707
[TBL] [Abstract][Full Text] [Related]
9. Pulsatile GnRH Therapy May Restore Hypothalamus-Pituitary-Testis Axis Function in Patients With Congenital Combined Pituitary Hormone Deficiency: A Prospective, Self-Controlled Trial.
Zheng J; Mao J; Xu H; Wang X; Huang B; Liu Z; Cui M; Xiong S; Ma W; Min L; Kaiser UB; Nie M; Wu X
J Clin Endocrinol Metab; 2017 Jul; 102(7):2291-2300. PubMed ID: 28368486
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy in patients with congenital hypogonadotropic hypogonadism: a multicentre clinical study.
Hao M; Mao JF; Guan QB; Tian L; Han H; Lei HE; Zheng DM; Tian ZH; Nie M; Wang X; Yu BQ; Gao YJ; Wu XY
Ann Transl Med; 2021 Jun; 9(12):962. PubMed ID: 34277762
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin Therapy Once a Week for Spermatogenesis in Hypogonadotropic Hypogonadism.
Ma W; Mao J; Nie M; Wang X; Zheng J; Liu Z; Yu B; Xiong S; Hao M; Gao Y; Ji W; Huang Q; Zhang R; Li S; Zhao Y; Sun B; Wu X
Endocr Pract; 2021 Nov; 27(11):1119-1127. PubMed ID: 33915281
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of pulsatile gonadotropin-releasing hormone therapy in male patients with hypogonadism caused by hypopituitarism.
Gu Y; Zhang S; Li X; Dou J; Lyu Z; Ba J; Guo Q; Zang L; Chen K; Du J; Pei Y; Mu Y; Gu W
Ann Palliat Med; 2021 Apr; 10(4):4642-4651. PubMed ID: 33966412
[TBL] [Abstract][Full Text] [Related]
13. [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism].
Huang B; Mao J; Xu H; Wang X; Liu Z; Nie M; Wu X
Zhonghua Yi Xue Za Zhi; 2015 May; 95(20):1568-71. PubMed ID: 26463603
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
Hao M; Nie M; Yu BQ; Gao YJ; Wang X; Ma WL; Huang QB; Zhang R; Mao JF; Wu XY
Asian J Androl; 2020; 22(4):390-395. PubMed ID: 31464203
[TBL] [Abstract][Full Text] [Related]
15. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
Delemarre-van de Waal HA
Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
[TBL] [Abstract][Full Text] [Related]
16. Pulsatile gonadotropin-releasing hormone treatment of men with idiopathic hypogonadotropic hypogonadism.
Christiansen P; Skakkebaek NE
Horm Res; 2002; 57(1-2):32-6. PubMed ID: 12006717
[TBL] [Abstract][Full Text] [Related]
17. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.
Sykiotis GP; Hoang XH; Avbelj M; Hayes FJ; Thambundit A; Dwyer A; Au M; Plummer L; Crowley WF; Pitteloud N
J Clin Endocrinol Metab; 2010 Jun; 95(6):3019-27. PubMed ID: 20382682
[TBL] [Abstract][Full Text] [Related]
18. Pulsatile luteinizing hormone-releasing hormone treatment of male hypogonadotropic hypogonadism.
Aulitzky W; Frick J; Galvan G
Fertil Steril; 1988 Sep; 50(3):480-6. PubMed ID: 3137102
[TBL] [Abstract][Full Text] [Related]
19. Hormonal control of spermatogenesis in men: therapeutic aspects in hypogonadotropic hypogonadism.
Pitteloud N; Dwyer A
Ann Endocrinol (Paris); 2014 May; 75(2):98-100. PubMed ID: 24793994
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
Finkelstein JS; Spratt DI; O'Dea LS; Whitcomb RW; Klibanski A; Schoenfeld DA; Crowley WF
J Clin Endocrinol Metab; 1989 Aug; 69(2):377-85. PubMed ID: 2502554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
